HSPG2 and acute lymphoblastic leukemia: This strongly suggests a need for inhibition of the corresponding RTK in the specific subgroups with low INPP5D expression, which could compensate for the loss of SHIP1 inhibition of the different signaling cascades (PI3K/AKT, MAPK, PLC) in T-ALL cells.